Zobrazeno 1 - 4
of 4
pro vyhledávání: '"May M. Alsaud"'
Publikováno v:
Molecules, Vol 28, Iss 12, p 4775 (2023)
Doxorubicin (DOX) is a chemotherapeutic agent that is linked with complications such as cardiotoxicity and cognitive dysfunction, known as chemobrain. Chemobrain affects up to 75% of cancer survivors, and there are no known therapeutic options for it
Externí odkaz:
https://doaj.org/article/da8a762f8f774003bfb8d9a67e311ff7
Publikováno v:
Molecules; Volume 28; Issue 12; Pages: 4775
Doxorubicin (DOX) is a chemotherapeutic agent that is linked with complications such as cardiotoxicity and cognitive dysfunction, known as chemobrain. Chemobrain affects up to 75% of cancer survivors, and there are no known therapeutic options for it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::b587dadb8ad385eec8e518f207f9a735
Autor:
Alsaud, May M.1 (AUTHOR) 431214396@qu.edu.sa, Alhowail, Ahmad H.1 (AUTHOR) aalhowail@qu.edu.sa, Aldubayan, Maha A.1 (AUTHOR), Almami, Ibtesam S.2 (AUTHOR) i.almami@qu.edu.sa
Publikováno v:
Molecules. Jun2023, Vol. 28 Issue 12, p4775. 14p.
Publikováno v:
Drug Week; 7/7/2023, p1437-1437, 1p